$TCDA Tricida, Inc. Insider Trading Week 47/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tricida, Inc. in week 47/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 1,884 | 3,165 | 1,885 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 1,884 | 3,165 | 1,885 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,355 | 1,884 | 0 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,355 | 1,884 | 0 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 2.39 | 1,507 | 3,602 | 18,844 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 2.39 | 1,507 | 3,602 | 18,844 | |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.60 | 1,884 | 74,606 | 0 | 1.9 K to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.60 | 1,884 | 74,606 | 0 | 1.9 K to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 1,884 | 3,165 | 1,884 | 0 to 1.9 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 1,884 | 3,165 | 1,884 | 0 to 1.9 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.59 | 739 | 29,257 | 0 | 739 to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.59 | 739 | 29,257 | 0 | 739 to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.60 | 1,616 | 63,994 | 739 | 2.4 K to 739 (-68.62 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.60 | 1,616 | 63,994 | 739 | 2.4 K to 739 (-68.62 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,355 | 1,884 | 2,355 | 0 to 2.4 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,355 | 1,884 | 2,355 | 0 to 2.4 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.61 | 1,507 | 59,692 | 0 | 1.5 K to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 39.61 | 1,507 | 59,692 | 0 | 1.5 K to 0 (-100.00 %) |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 2.39 | 1,507 | 3,602 | 1,507 | 0 to 1.5 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 2.39 | 1,507 | 3,602 | 1,507 | 0 to 1.5 K |
| Nov 27 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.59 | 1,000 | 39,590 | 137,390 | 138.4 K to 137.4 K (-0.72 %) |
| Nov 26 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 41.17 | 132,834 | 5,468,776 | 2,773,350 | 2.9 M to 2.8 M (-4.57 %) |
| Nov 26 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 40.53 | 48,030 | 1,946,656 | 2,906,184 | 3 M to 2.9 M (-1.63 %) |
| Nov 26 2019 | TCDA | Tricida, Inc. | Isern Brian M. | 10% Owner | Sell | S | 41.17 | 132,834 | 5,468,776 | 2,773,350 | 2.9 M to 2.8 M (-4.57 %) |
| Nov 26 2019 | TCDA | Tricida, Inc. | Isern Brian M. | 10% Owner | Sell | S | 40.53 | 48,030 | 1,946,656 | 2,906,184 | 3 M to 2.9 M (-1.63 %) |